What Evnia does

Evnia is a Copenhagen-based MedTech and BioTech consulting firm specializing in the full lifecycle management of medical devices and in-vitro diagnostics. The company supports manufacturers from early concept and design stages through verification, validation, market access, and post-market adulthood, with particular depth in EU MDR/IVDR, UK Medical Devices Regulation 2002, and international regulatory frameworks. Its service portfolio spans clinical evaluation reports, post-market clinical follow-up (PMCF) plans and surveys, technical documentation, regulatory affairs management, real-world evidence generation, and IVDR performance evaluation. Evnia also acts as an EU Authorised Representative and UK Responsible Person for non-EU and non-UK manufacturers seeking European market access.

The firm operates three proprietary software solutions that augment its consulting practice: EVA (Evnia Vigilance Algorithm), an automated tool that scans and reports incidents from multiple vigilance databases in real time; Iris, a regulatory management solution platform; and Triad, an integrated regulatory and clinical services platform. Together with streamlined processes and accumulated audit success, these tools form the basis of the firm's technology layer within an otherwise professional services offering.

Evnia's business model is professional services-based, with project-based engagements and retainer arrangements tailored to client needs across three primary size segments — Billion+ multinationals (e.g., Novartis, Merck, Novo Nordisk, Roche, Johnson & Johnson, Thermo Fisher Scientific), midsize MedTech/BioTech firms, and startup manufacturers. The company employs 101-250 professionals, holds memberships in RAPs and the Health Industry Association, and operates as a privately held, organically grown firm headquartered in Denmark. Its go-to-market is sales-led and relationship-driven, supported by content marketing, webinars (including co-hosted sessions with Notified Body BSI), industry events, and a global direct consulting engagement model.

Name

Evnia

Legal name

Evnia

Website

https://evnia.dk

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Evnia is a Copenhagen-based MedTech/BioTech consulting firm providing end-to-end medical device and IVD regulatory lifecycle services — from clinical evaluation and technical documentation to EU Authorised Representative and UK Responsible Person mandates — serving enterprise, midsize, and startup manufacturers globally.

Ownership category

akta.pro rank

Product category

Medical Device Regulatory Consulting

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

akta.pro secondary industry

Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)

Keywords

• Medical device consulting
• Regulatory affairs services
• Clinical evaluation reports
• Post-market surveillance
• EU MDR compliance

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Consulting Services: Professional consulting services for medical device lifecycle management including regulatory affairs, clinical evaluations, technical documentation, and post-market surveillance. Revenue is generated through project-based engagements and retainer arrangements with MedTech and BioTech manufacturers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Evnia provides expert medical device lifecycle management consulting services to MedTech and BioTech manufacturers, covering the full development roadmap from early concept and design through verification, validation, market access, and post-market adulthood. Its portfolio spans regulatory affairs management, clinical evaluation reports, post-market clinical follow-up (PMCF) plans and surveys, technical documentation, IVDR compliance, and real-world evidence generation, supplemented by proprietary tools including the EVA automated vigilance algorithm and the Iris and Triad solution platforms.

Product overview

Evnia is a MedTech/BioTech consulting services company offering expert medical device lifecycle management services. The company provides an integrated portfolio of regulatory and clinical services including Clinical Evaluation Reports, PMCF Planning, Technical Documentation, IVDR compliance, Regulatory Affairs Management, and Real World Evidence generation. Evnia also offers proprietary tools including EVA (an automated vigilance algorithm), Iris, and Triad, as well as EU and UK Authorized Representative services. The portfolio ranges from early concept and design stages through verification and validation to market access and post-market support.

Differentiator

Problem solved

Functional benefit

Products and services

• Real World Evidence (RWE) A cluster of services for generating real-world evidence to support clinical development strategy throughout the entire lifetime of medical devices, including registry development, clinical experience data collection, and PMCF survey conduct, targeted at MedTech and BioTech manufacturers.
• Clinical Evaluation Reports Refined clinical evaluation process ensuring comprehensive assessment of a medical device's safety and performance profile, with a track record of proven audit success, delivered to medical device manufacturers.
• PMCF Plans and Surveys Post-Market Clinical Follow-up services mandated by Medical Device Regulation, involving continuous collection and evaluation of clinical data to confirm safety and performance throughout a device's expected lifetime, for medical device manufacturers.
• Technical Documentation Full spectrum of services covering key areas of technical and clinical documentation including usability engineering, risk management, procedure and benefit-risk analysis, and validation, for medical device manufacturers under MDR.
• In-Vitro Diagnostic Regulation (IVDR) Services Guidance and preparation of performance evaluation plans and reports to ensure in-vitro diagnostic medical device compliance under IVDR, for IVD manufacturers.
• Regulatory Affairs Management Project management and interim management services for Medical Device and Pharma organisations providing a holistic approach to unique business regulatory requirements.
• EVA (Evnia Vigilance Algorithm) An automated vigilance algorithm that scans, analyses, and reports incidents from multiple vigilance databases in real time, offered as a proprietary solution for medical device post-market surveillance.
• Iris A proprietary solution platform for medical device regulatory management, listed under Evnia's Solutions portfolio.
• Triad A proprietary solution platform for integrated regulatory and clinical services, listed under Evnia's Solutions portfolio.
• EU Authorised Representative EU Authorised Representative services required by MDR/IVDR Article 11 for medical device and in-vitro diagnostic manufacturers based outside the EU that wish to sell products in any EU Member State.
• UK Responsible Person UK Responsible Person services required under the UK Medical Devices Regulation 2002 for manufacturers located outside the UK that want to place a medical device or IVD on the Great Britain market.

Quantifiable outcome

• Proven audit success in clinical evaluation processes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• BSIcoreStrategic or Co-development PartnerBSI is a leading Notified Body and regulatory compliance organization. Evnia co-hosts webinars with BSI on regulatory topics such as real-world data for medical devices under MDR, demonstrating a strategic educational partnership.
• Health Industry Association (HIA)minorStrategic or Co-development PartnerIndustry association membership providing access to regulatory network and industry resources.
• Confederation of Danish Industry (DI)minorStrategic or Co-development PartnerTrade association membership representing Danish business interests in the healthcare and life sciences sector.
• Medicon ValleyminorStrategic or Co-development PartnerCross-border life science cluster partnership in the Øresund region connecting Denmark and Sweden.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Qserve Group: Dutch-headquartered MedTech regulatory and quality consulting firm offering MDR/IVDR compliance, clinical evaluation, and Notified Body readiness services across Europe — directly overlapping Evnia's core service portfolio and target customer base.
• RQM+: US-based MedTech regulatory and quality consulting firm providing MDR/IVDR transition support, clinical evaluation reports, and post-market services — a direct competitor for the same enterprise MedTech manufacturers Evnia serves.
• Maetrics: European MedTech regulatory and quality compliance consultancy delivering technical documentation, clinical evaluation, and ISO 13485/QSR services — closely overlapping with Evnia's lifecycle coverage.
• Celegence: Regulatory affairs consulting firm specializing in MDR/IVDR compliance, clinical evaluation, and regulatory publishing for medical device manufacturers — directly comparable in scope and target market to Evnia.
• ProPharma Group: Life sciences regulatory and compliance consultancy with a dedicated MedTech practice covering MDR/IVDR, quality systems, and clinical evidence — competing for the same enterprise medical device engagements.
• Pharmalex: Regulatory affairs and compliance consultancy serving pharma and medical device companies across Europe — provides regulatory strategy, submissions, and lifecycle management overlapping with Evnia's offerings.
• MakroCare: Global clinical research and regulatory services firm offering MDR/IVDR consulting, clinical evaluation, and post-market surveillance — competing in the same medical device regulatory consulting category.

Broad incumbents

• IQVIA: Global CRO and life sciences services giant offering regulatory affairs, clinical evaluation, and post-market services as part of a broad portfolio — competes for enterprise MedTech accounts but not specialized in Evnia's European regulatory niche.
• Parexel International: Large global CRO with a regulatory consulting practice serving pharma and MedTech manufacturers — competes for the same enterprise regulatory work as part of a much broader clinical and commercialization portfolio.
• ICON plc: Global CRO providing regulatory consulting and clinical services to medical device and pharmaceutical clients — overlaps with Evnia on regulatory affairs but competes across a vastly broader service portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/evnia_dk
• LinkedInlinkedin.com/company/evnia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evnia